Company to Host Conference Call Today, August 7th, at 4:30pm ET BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announces its financial results for the quarter ended June 30, 2025 and provides a business update. Q2 2025 and Recent Corporate Highlights DN-TNF Platform Highlights (XPro™): Figure Legend: With the enriche ...